Colorectal Neuroendocrine Neoplasms: Areas of Unmet Need.

Carcinoid tumours Gastroenteropancreatic neuroendocrine tumours Neuroendocrine tumour Somatostatin receptor

Journal

Neuroendocrinology
ISSN: 1423-0194
Titre abrégé: Neuroendocrinology
Pays: Switzerland
ID NLM: 0035665

Informations de publication

Date de publication:
2019
Historique:
received: 01 07 2018
accepted: 14 09 2018
pubmed: 17 9 2018
medline: 18 12 2019
entrez: 17 9 2018
Statut: ppublish

Résumé

The subject of colorectal neuroendocrine neoplasms (NENs), subdivided into well-differentiated NENs, termed neuroendocrine tumours (NETs; grade (G) 1 and 2), and poorly differentiated NENs, termed neuroendocrine carcinomas (NECs; G3) according to the 2010 World Health Organisation (WHO) classification, has arguably not had as much attention or study as NENs occurring in other sites. Colorectal NETs and NECs are however easier to study than many others since they are usually not difficult to remove and are increasingly detected because of intensified colorectal cancer screening and surveillance programmes. Colorectal NETs and NECs show site-specific heterogeneity with variable behaviour and different therapeutic options; these various aspects provide unique challenges. Because of bowel cancer screening programmes, colorectal NENs, like conventional adenocarcinomas, may be diagnosed at a stage that is associated with improved survival. In this article we intend to describe and define areas of unmet needs relating to the epidemiology, classification, pathology, diagnosis and therapy of colorectal NETs (including NETs G3), colorectal NECs, and finally, mixed adeno-neuroendocrine carcinomas (MANECs) by reviewing and discussing the relevant literature.

Identifiants

pubmed: 30219817
pii: 000493767
doi: 10.1159/000493767
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

45-53

Investigateurs

Detlef Bartsch (D)
Rudolf Arnold (R)
Eric Baudin (E)
Lisa Bodei (L)
Ivan Borbath (I)
Jaume Capdevila (J)
Martyn Caplin (M)
Jie Chen (J)
Frederico Costa (F)
Anne Couvelard (A)
Jaroslaw Ćwikła (J)
Philippa Davies (P)
Herder de (H)
Massimo Falconi (M)
Jenny Falkerby (J)
Nicola Fazio (N)
Diego Ferone (D)
Andrea Frilling (A)
Rocio Garcia-Carbonero (R)
Simona Glasberg (S)
Vera Gorbunova (V)
Ashley Grossman (A)
Dieter Hörsch (D)
Robert Jensen (R)
Gregory Kaltsas (G)
Günter Klöppel (G)
Ulrich Knigge (U)
Beata Kos-Kudła (B)
Guenter Krejs (G)
Eric Krenning (E)
Matthew Kulke (M)
Steven Lamberts (S)
van Nieveen (V)
Juan O'Connor (J)
Dermot O'Toole (D)
Ulrich-Frank Pape (UF)
Stefano Partelli (S)
Marianne Pavel (M)
Marc Peeters (M)
John Ramage (J)
Nicholas Reed (N)
Guido Rindi (G)
Anja Rinke (A)
Philippe Ruszniewski (P)
Halfdan Sorbye (H)
Anders Sundin (A)
Jean-Yves Scoazec (JY)
Babs Taal (B)
Janson Tiensuu (J)
Christos Toumpanakis (C)
Juan Valle (J)
Marie-Pierre Vullierme (MP)
Staffan Welin (S)
Bertram Wiedenmann (B)

Informations de copyright

© 2018 S. Karger AG, Basel.

Auteurs

John K Ramage (JK)

Department Gastroenterology, Hampshire Hospitals NHS Trust, Kings College Hospital ENETS centre of Excellence, Basingstoke, United Kingdomjohn.ramage@hhft.nhs.uk.

Juan W Valle (JW)

Department of Medical Oncology, University of Manchester, The Christie ENETS Centre of Excellence, Manchester, United Kingdom.

Els J M Nieveen van Dijkum (EJM)

Department of Surgery, Amsterdam, The Netherlands.

Anders Sundin (A)

Department of Radiology, Institution Surgical Sciences, Uppsala University and ENETS centre of excellence, Uppsala University Hopsital, Uppsala, Sweden.

Andreas Pascher (A)

Department of Surgery, Charité Universitaetsmedizin Berlin, Berlin, Germany.
Department of Visceral and Transplant Surgery, University of Muenster, Muenster, Germany.

Anne Couvelard (A)

Department of Pathology, Bichat Hospital AP-HP and University of Paris Diderot, Paris, France.

Guenter Kloeppel (G)

Department of Pathology, Technical University Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH